AMZN
Amazon.com, Inc.
AMZN has the edge over BLMN overall, supported by lower modeled downside and stronger modeled upside.
BLMN
Bloomin' Brands, Inc.
BLMN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BLMN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BLMN's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BLMN in the historical PE scenario, which offers more potential upside but is not a forecast.
BLMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $10.12 | — |
| Cheap | 9.8x | $8.08 | -20% |
| Current | 12x | $10.12 | — |
| Fair | 22x | $18.19 | +80% |
| Expensive | 34x | $27.95 | +176% |
Historical ranges are pointers, not guarantees.
BLMN's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BLMN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect BLMN's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BLMN on earnings, with more consistent year-over-year improvement.
BLMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.09 | +33% |
| Q3 2026 | $0.82 | +$1.49 |
| Q2 2026 | $0.31 | +$0.36 |
| Q1 2026 | $0.25 | +$0.28 |
| Q4 2025 | $0.10 | +$1.59 |
| Q3 2025 | -$0.67 | -$0.59 |
| Q2 2025 | -$0.05 | -117% |
| Q1 2025 | -$0.03 | -104% |
| Q4 2024 | -$1.49 | -158% |
BLMN has returned to profit: it earned $0.82 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BLMN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BLMN on profitability, with a higher operating margin.
BLMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $944.3M | +1.7% |
| Q2 2026 | $1B | +1.3% |
| Q1 2026 | $1.1B | +1% |
| Q4 2025 | $975.2M | +0.3% |
| Q3 2025 | $928.8M | -11% |
| Q2 2025 | $1B | -10% |
| Q1 2025 | $1B | -12% |
| Q4 2024 | $972M | -19% |
BLMN's revenue fell from its 2023 peak and has held roughly level since: $944M last quarter, up 1.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2% | +5.9 points |
| Q2 2026 | 3.8% | +0.8 points |
| Q1 2026 | 5.6% | +0.1 points |
| Q4 2025 | -1.4% | -3 points |
| Q3 2025 | -3.9% | -5.6 points |
| Q2 2025 | 3% | -1.2 points |
| Q1 2025 | 5.5% | -1 points |
| Q4 2024 | 1.7% | -3.1 points |
BLMN's operating margin was 2% last quarter, up 5.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BLMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.2M | -$33.5M |
| Q2 2026 | $46.9M | +321% |
| Q1 2026 | $50.1M | +81% |
| Q4 2025 | $63.7M | -35% |
| Q3 2025 | -$5.7M | +$69.2M |
| Q2 2025 | $11.1M | +$35.4M |
| Q1 2025 | $27.7M | +211% |
| Q4 2024 | $97.7M | +58% |
BLMN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BLMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -587K shares |
| 1 year | +0.6% | +543K shares |
| 3 years | -13% | -12.9M shares |
| 5 years | -21% | -22.1M shares |
| Available history | -4.6% | -4.1M shares |
BLMN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $18.2M |
| Q2 2024 | $14.6M |
| Q1 2024 | $232.9M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BLMN on leverage, with a lower net debt burden relative to earnings.
BLMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.9x | Moderate |
BLMN's net debt is about 2.4 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BLMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 53.6 | Neutral |
BLMN's weekly RSI is 56 (neutral) and its Stochastic is 54 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
BLMN PE vs Consumer Cyclical Sector
| Metric | BLMN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 32% below |
| PE % | 31 | 47 | 16 pts below |
BLMN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BLMN on trend strength, trading above more of its moving averages.
BLMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.32 | 8.6% above |
| 20 week MA | $9.35 | 8.2% above |
| 50 week MA | $7.86 | 29% above |
| 100 week MA | $8.25 | 23% above |
| 200 week MA | $15.7 | 36% below |
BLMN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 36% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
BLMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $19.0 | -13% |
| 2021 | $19.0 | $21.0 | +11% |
| 2022 | $21.0 | $21.0 | 0% |
| 2023 | $21.0 | $28.2 | +34% |
| 2024 | $28.2 | $12.3 | -56% |
| 2025 | $12.3 | $6.79 | -45% |
| 2026 YTD | $6.79 | $10.1 | +49% |
BLMN has the edge over AMZN on returns for 2026, with the stronger performance.